Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Nuclear Medicine

Free Subscription Articles published in Neurology Retrieve available abstracts of 190 articles: HTML format

Single Articles

July 2021
1. WOLTERS EE, Papma JM, Verfaillie SCJ, Visser D, et al
   [18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers.
   Neurology. 2021 Jul 1. pii: WNL.0000000000012448.
   PubMed     Abstract available
   
   
   June 2021
2. TODISCO M, Zangaglia R, Minafra B, Pisano P, et al
   Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus.
   Neurology. 2021;96:e2861-e2873.
   PubMed     Abstract available
   
   
   May 2021
3. MAYBLYUM DV, Becker JA, Jacobs HIL, Buckley RF, et al
   Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease.
   Neurology. 2021 May 5. pii: WNL.0000000000012108.
   PubMed     Abstract available
   
   
   April 2021
4. RIOU A, Houvenaghel JF, Dondaine T, Drapier S, et al
   Functional Role of the Cerebellum in Parkinson Disease: A PET Study.
   Neurology. 2021 Apr 28. pii: WNL.0000000000012036.
   PubMed     Abstract available
   
   
   
5. NASCIMENTO FA, Cochran RL, Chow DZ, Scott JA, et al
   Teaching NeuroImages: Increasing SPECTations for Ictal SPECT in Epilepsy Surgical Evaluation.
   Neurology. 2021 Apr 26. pii: WNL.0000000000012097.
   PubMed    
   
   
   
6. VAN DEN AMEELE J, Hong Y, Manavaki R, Kouli A, et al
   [11C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease.
   Neurology. 2021 Apr 21. pii: WNL.0000000000012033.
   PubMed     Abstract available
   
   
   
7. ROBERTS G, Durcan Mrcpi R, Donaghy PC, Lawley S, et al
   Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
   Neurology. 2021 Apr 21. pii: WNL.0000000000012060.
   PubMed     Abstract available
   
   
   
8. SCHOEMAKER D, Charidimou A, Zanon Zotin MC, Raposo N, et al
   Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy.
   Neurology. 2021;96:e1975-e1986.
   PubMed     Abstract available
   
   
   March 2021
9. TOPPALA S, Ekblad LL, Tuisku J, Helin S, et al
   Association of Early beta-Amyloid Accumulation and Neuroinflammation Measured With [(11)C]PBR28 in Elderly Individuals Without Dementia.
   Neurology. 2021;96:e1608-e1619.
   PubMed     Abstract available
   
   
   
10. POIRION E, Tonietto M, Lejeune FX, Ricigliano VAG, et al
    Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis.
    Neurology. 2021 Mar 18. pii: WNL.0000000000011700.
    PubMed     Abstract available
    
    
    
11. GOTTESMAN RF, Hamilton R
    Recruiting Diverse Populations in Clinical Trials: How Do We Overcome Selection Bias?
    Neurology. 2021;96:509-510.
    PubMed    
    
    
    
12. SEKIGUCHI T, Kanazawa T, Ohkubo T
    Teaching Video NeuroImages: Choreoathetosis Due to Radiation-Induced Brachial Plexopathy.
    Neurology. 2021;96:e1489-e1490.
    PubMed    
    
    
    
13. 
    Decreased GABA-A Binding on FMZ-PET in Succinic Semialdehyde Dehydrogenase Deficiency.
    Neurology. 2021 Mar 8. pii: WNL.0000000000011754.
    PubMed    
    
    
    
14. BARKHOF BF, Pressman PS
    Time Is of the Essence: Early Detection of Incipient Alzheimer Pathology.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011739.
    PubMed    
    
    
    February 2021
15. THERRIAULT J, Pascoal TA, Benedet AL, Tissot C, et al
    Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE epsilon4, and Cognitive Impairment.
    Neurology. 2021;96:e975-e985.
    PubMed     Abstract available
    
    
    
16. RENTZ DM, Papp KV, Mayblyum DV, Sanchez JS, et al
    Association of Digital Clock Drawing with PET Amyloid and Tau Pathology in Normal Older Adults.
    Neurology. 2021 Feb 15. pii: WNL.0000000000011697.
    PubMed     Abstract available
    
    
    
17. DETERS K, Napolioni V, Sperling RA, Greicius MD, et al
    Amyloid PET imaging in self-identified non-Hispanic Blacks from the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study.
    Neurology. 2021 Feb 10. pii: WNL.0000000000011599.
    PubMed     Abstract available
    
    
    
18. LEE R, Shin JH, Choi H, Kim HJ, et al
    Variability of FP-CIT PET Patterns Associated with Clinical Features of Multiple System Atrophy.
    Neurology. 2021 Feb 3. pii: WNL.0000000000011634.
    PubMed     Abstract available
    
    
    
19. MALTETE D, Wallon D, Bourilhon J, Lefaucheur R, et al
    Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial.
    Neurology. 2021;96:e684-e697.
    PubMed     Abstract available
    
    
    
20. VAN DER KALL LM, Truong T, Burnham SC, Dore V, et al
    Association of beta-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals.
    Neurology. 2021;96:e662-e670.
    PubMed     Abstract available
    
    
    January 2021
21. BLAZHENETS G, Frings L, Ma Y, Sorensen A, et al
    Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011521.
    PubMed     Abstract available
    
    
    
22. JAGUST WJ, Landau SM
    Temporal Dynamics of Beta-amyloid Accumulation in Aging and Alzheimer's Disease.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011524.
    PubMed     Abstract available
    
    
    December 2020
23. KNOPMAN DS, Jagust WJ
    Alzheimer Disease Spectrum: Syndrome and Etiology from Clinical and PET Imaging Perspectives.
    Neurology. 2020 Dec 22. pii: WNL.0000000000011415.
    PubMed    
    
    
    
24. FERREIRA D, Przybelski SA, Lesnick TG, Lemstra AW, et al
    beta-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies.
    Neurology. 2020;95:e3257-e3268.
    PubMed     Abstract available
    
    
    
25. SHIN JH, Lee JY, Kim YK, Shin SA, et al
    Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
    Neurology. 2020;95:e3081-e3092.
    PubMed     Abstract available
    
    
    
26. LA JOIE R, Visani AV, Lesman-Segev OH, Baker SL, et al
    Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011270.
    PubMed     Abstract available
    
    
    
27. OLIVOT JM
    Beyond mismatch, perfusion imaging predicts infarct growth before revascularization.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011271.
    PubMed    
    
    
    November 2020
28. FARRELL ME, Jiang S, Schultz AP, Properzi MJ, et al
    Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation.
    Neurology. 2020 Nov 16. pii: WNL.0000000000011214.
    PubMed     Abstract available
    
    
    
29. ILLAN-GALA I, Lleo A, Karydas A, Staffaroni AM, et al
    Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer's disease.
    Neurology. 2020 Nov 16. pii: WNL.0000000000011226.
    PubMed     Abstract available
    
    
    
30. HAN JW, Maillard P, Harvey D, Fletcher E, et al
    Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory.
    Neurology. 2020;95:e2622-e2634.
    PubMed     Abstract available
    
    
    
31. FOSTER CM, Kennedy KM, Daugherty AM, Rodrigue KM, et al
    Contribution of iron and Abeta to age differences in entorhinal and hippocampal subfield volume.
    Neurology. 2020;95:e2586-e2594.
    PubMed     Abstract available
    
    
    
32. LIM YY, Baker JE, Bruns L Jr, Mills A, et al
    Association of deficits in short-term learning and Abeta and hippocampal volume in cognitively normal adults.
    Neurology. 2020;95:e2577-e2585.
    PubMed     Abstract available
    
    
    October 2020
33. KERCHNER GA, Filippi M
    Abeta-PET pathology accumulation index: Ready for the clinic?
    Neurology. 2020 Oct 19. pii: WNL.0000000000011060.
    PubMed    
    
    
    
34. LEUZY A, Lilja J, Buckley CJ, Ossenkoppele R, et al
    Derivation and utility of an Abeta-PET pathology accumulation index to estimate Abeta load.
    Neurology. 2020 Oct 19. pii: WNL.0000000000011031.
    PubMed     Abstract available
    
    
    
35. MENDEZ-GUERRERO A, Laespada-Garcia MI, Gomez-Grande A, Ruiz-Ortiz M, et al
    Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection.
    Neurology. 2020;95:e2109-e2118.
    PubMed     Abstract available
    
    
    
36. GERTJE EC, van Westen D, Panizo C, Mattsson-Carlgren N, et al
    Association of enlarged perivascular spaces and measures of small vessel and Alzheimers disease.
    Neurology. 2020 Oct 12. pii: WNL.0000000000011046.
    PubMed    
    
    
    
37. CATRICALA E, Polito C, Presotto L, Esposito V, et al
    Neural correlates of naming errors across different neurodegenerative diseases: A FDG-PET study.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010967.
    PubMed     Abstract available
    
    
    September 2020
38. WHITWELL JL, Tosakulwong N, Schwarz CC, Senjem ML, et al
    Longitudinal anatomic, functional and molecular characterization of Pick's disease phenotypes.
    Neurology. 2020 Sep 28. pii: WNL.0000000000010948.
    PubMed     Abstract available
    
    
    
39. SAN LEE J, Lee H, Park S, Choe Y, et al
    Association between APOE epsilon2 and Abeta burden in patients with Alzheimer- and Vascular-Type Cognitive Impairment.
    Neurology. 2020 Sep 14. pii: WNL.0000000000010811.
    PubMed     Abstract available
    
    
    
40. REIMAND J, Collij L, Scheltens P, Bouwman F, et al
    Association of amyloid-beta CSF/PET discordance and tau load five years later.
    Neurology. 2020 Sep 10. pii: WNL.0000000000010739.
    PubMed     Abstract available
    
    
    
41. GUZMAN-VELEZ E, Martinez J, Papp K, Baena A, et al
    Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers.
    Neurology. 2020;95:e1312-e1321.
    PubMed     Abstract available
    
    
    
42. LUO J, Agboola F, Grant E, Masters CL, et al
    Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study.
    Neurology. 2020 Sep 1. pii: WNL.0000000000010747.
    PubMed     Abstract available
    
    
    August 2020
43. SNITZ BE, Chang Y, Tudorascu DL, Lopez OL, et al
    Predicting resistance to amyloid-beta deposition and cognitive resilience in the oldest-old.
    Neurology. 2020;95:e984-e994.
    PubMed     Abstract available
    
    
    
44. KIM JW, Byun MS, Lee JH, Yi D, et al
    Serum albumin and beta-amyloid deposition in the human brain.
    Neurology. 2020;95:e815-e826.
    PubMed     Abstract available
    
    
    
45. WANG L, Cheng W, Rolls E, Dai F, et al
    Association of specific biotypes in patients with Parkinson disease and disease progression.
    Neurology. 2020 Aug 14. pii: WNL.0000000000010498.
    PubMed     Abstract available
    
    
    
46. VAN DER ZANDE JJ, Gouw AA, van Steenoven I, van de Beek M, et al
    Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies.
    Neurology. 2020;95:e662-e670.
    PubMed     Abstract available
    
    
    
47. GUO T, Shaw LM, Trojanowski JQ, Jagust WJ, et al
    Association of CSF Abeta, amyloid PET and cognition in cognitively unimpaired elderly adults.
    Neurology. 2020 Aug 5. pii: WNL.0000000000010596.
    PubMed     Abstract available
    
    
    
48. VANHAUTE H, Ceccarini J, Michiels L, Koole M, et al
    In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment.
    Neurology. 2020;95:e545-e553.
    PubMed     Abstract available
    
    
    
49. CHAHINE LM, Beach TG, Brumm MC, Adler CH, et al
    In vivo distribution of alpha-synuclein in multiple tissues and biofluids in Parkinson disease.
    Neurology. 2020 Aug 3. pii: WNL.0000000000010404.
    PubMed     Abstract available
    
    
    July 2020
50. VAN HARTEN AC, Wiste HJ, Weigand SD, Mielke MM, et al
    CSF biomarkers in Olmsted County: Evidence of 2 subclasses and associations with demographics.
    Neurology. 2020;95:e256-e267.
    PubMed     Abstract available
    
    
    
51. COLLIJ LE, Heeman F, Salvado G, Ingala S, et al
    Multi-tracer model for staging cortical amyloid deposition using PET imaging.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010256.
    PubMed     Abstract available
    
    
    
52. LIU J, Peedicail JS, Gaxiola-Valdez I, Li E, et al
    Postictal brainstem hypoperfusion and risk factors for sudden unexpected death in epilepsy.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010360.
    PubMed     Abstract available
    
    
    
53. THALER AI, Kim BD, Fara MG
    Teaching NeuroImages: MR Perfusion and Diffusion Findings in Hemiplegic Migraine.
    Neurology. 2020 Jul 9. pii: WNL.0000000000010249.
    PubMed    
    
    
    
54. KHEDER A, Thome U, Aung T, Krishnan B, et al
    Investigation of Networks Underlying Hyperkinetic Seizures utilizing Ictal SPECT.
    Neurology. 2020 Jul 7. pii: WNL.0000000000009975.
    PubMed     Abstract available
    
    
    
55. CHUNG SJ, Lee HS, Yoo HS, Lee YH, et al
    Patterns of striatal dopamine depletion in early Parkinson disease: Prognostic relevance.
    Neurology. 2020 Jul 2. pii: WNL.0000000000009878.
    PubMed     Abstract available
    
    
    June 2020
56. BEJANIN A, Tammewar G, Marx G, Cobigo Y, et al
    Longitudinal structural and metabolic changes in frontotemporal dementia.
    Neurology. 2020 Jun 26. pii: WNL.0000000000009760.
    PubMed     Abstract available
    
    
    
57. RAHMAN A, Schelbaum E, Hoffman K, Diaz I, et al
    Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
    Neurology. 2020 Jun 24. pii: WNL.0000000000009781.
    PubMed     Abstract available
    
    
    
58. LEE Y, Ko J, Choi YE, Oh JS, et al
    Areas of white matter hyperintensities and motor symptoms of Parkinson disease.
    Neurology. 2020 Jun 23. pii: WNL.0000000000009890.
    PubMed     Abstract available
    
    
    
59. BUCIUC M, Botha H, Murray ME, Schwarz CG, et al
    Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.
    Neurology. 2020 Jun 9. pii: WNL.0000000000009722.
    PubMed     Abstract available
    
    
    May 2020
60. MATTSSON-CARLGREN N, Leuzy A, Janelidze S, Palmqvist S, et al
    The implications of different approaches to define AT(N) in Alzheimer disease.
    Neurology. 2020 May 12. pii: WNL.0000000000009485.
    PubMed     Abstract available
    
    
    
61. JACOBS HIL, Augustinack JC, Schultz AP, Hanseeuw BJ, et al
    The presubiculum links incipient amyloid and tau pathology to memory function in older persons.
    Neurology. 2020;94:e1916-e1928.
    PubMed     Abstract available
    
    
    April 2020
62. ARUN T, Pattison L, Palace J
    Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study.
    Neurology. 2020 Apr 30. pii: WNL.0000000000009491.
    PubMed     Abstract available
    
    
    
63. VILAPLANA E, Rodriguez-Vieitez E, Ferreira D, Montal V, et al
    Cortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer disease.
    Neurology. 2020 Apr 14. pii: WNL.0000000000009405.
    PubMed     Abstract available
    
    
    
64. PARK DC, Abner EL
    Amyloid deposits in the banks (of the superior temporal sulcus) yield a high return about memory futures.
    Neurology. 2020;94:603-604.
    PubMed    
    
    
    March 2020
65. YOO HS, Lee S, Chung SJ, Lee YH, et al
    Clinical and striatal dopamine transporter predictors of beta-amyloid in dementia with Lewy bodies.
    Neurology. 2020;94:e1344-e1352.
    PubMed     Abstract available
    
    
    
66. BREMOVA-ERTL T, Sztatecsny C, Brendel M, Moser M, et al
    Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity.
    Neurology. 2020 Mar 31. pii: WNL.0000000000009290.
    PubMed     Abstract available
    
    
    
67. CARVALHO DZ, St Louis EK, Schwarz CG, Lowe VJ, et al
    Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly.
    Neurology. 2020 Mar 26. pii: WNL.0000000000009315.
    PubMed     Abstract available
    
    
    
68. WALTERFANG M, Di Biase MA, Cropley VL, Scott AM, et al
    Imaging of neuroinflammation in adult Niemann-Pick type C disease: A cross-sectional study.
    Neurology. 2020 Mar 24. pii: WNL.0000000000009287.
    PubMed     Abstract available
    
    
    
69. GUO T, Landau SM, Jagust WJ
    Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults.
    Neurology. 2020 Mar 18. pii: WNL.0000000000009216.
    PubMed     Abstract available
    
    
    
70. DOECKE JD, Perez-Grijalba V, Fandos N, Fowler C, et al
    Total Abeta42/Abeta40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis.
    Neurology. 2020 Mar 16. pii: WNL.0000000000009240.
    PubMed     Abstract available
    
    
    
71. SWERDLOW RH
    Mitochondria in Alzheimer brains: A PET project shows complex changes.
    Neurology. 2020 Mar 5. pii: WNL.0000000000009236.
    PubMed    
    
    
    February 2020
72. SCHOBERL F, Pradhan C, Irving S, Buerger K, et al
    Real-space navigation testing differentiates between amyloid-positive and -negative aMCI.
    Neurology. 2020;94:e861-e873.
    PubMed     Abstract available
    
    
    
73. CARLISLE TC, Galetta KM, McGinnis SM, Bockow Kaplan T, et al
    Clinical Reasoning: A 58-year-old woman presents with progressive memory deficits, odd behavior, and falls.
    Neurology. 2020;94:e557-e561.
    PubMed    
    
    
    
74. MCSWEENEY M, Pichet Binette A, Meyer PF, Gonneaud J, et al
    Intermediate flortaucipir uptake is associated with Abeta-PET and CSF-tau in asymptomatic adults.
    Neurology. 2020 Feb 3. pii: WNL.0000000000008905.
    PubMed     Abstract available
    
    
    January 2020
75. THOMAS KR, Bangen KJ, Weigand AJ, Edmonds EC, et al
    Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration.
    Neurology. 2020;94:e397-e406.
    PubMed     Abstract available
    
    
    
76. MARTERSTECK A, Sridhar J, Rader B, Coventry C, et al
    Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease.
    Neurology. 2020 Jan 22. pii: WNL.0000000000008960.
    PubMed     Abstract available
    
    
    
77. GRAFF-RADFORD J, Lesnick T, Rabinstein AA, Gunter J, et al
    Cerebral microbleed incidence, relationship to amyloid burden: The Mayo Clinic Study of Aging.
    Neurology. 2020;94:e190-e199.
    PubMed     Abstract available
    
    
    December 2019
78. LANDAU SM, Villemagne VL
    Can amyloid PET differentiate "pure" LBD from AD with or without LBD copathology?
    Neurology. 2019 Dec 20. pii: WNL.0000000000008812.
    PubMed    
    
    
    
79. KANTARCI K, Lowe VJ, Chen Q, Przybelski SA, et al
    beta-Amyloid PET and neuropathology in dementia with Lewy bodies.
    Neurology. 2019 Dec 20. pii: WNL.0000000000008818.
    PubMed     Abstract available
    
    
    
80. CAMPBELL MC, Jackson JJ, Koller JM, Snyder AZ, et al
    Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease.
    Neurology. 2019 Dec 18. pii: WNL.0000000000008677.
    PubMed     Abstract available
    
    
    
81. CAVEDO E, Lista S, Houot M, Vergallo A, et al
    Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease.
    Neurology. 2019 Dec 4. pii: WNL.0000000000008696.
    PubMed     Abstract available
    
    
    November 2019
82. BENARROCH EE
    Insular cortex: Functional complexity and clinical correlations.
    Neurology. 2019;93:932-938.
    PubMed    
    
    
    
83. ZHOU Z, Muller MLTM, Kanel P, Chua J, et al
    Apathy rating scores and beta-amyloidopathy in Parkinson disease patients at risk for cognitive decline.
    Neurology. 2019 Nov 15. pii: WNL.0000000000008683.
    PubMed     Abstract available
    
    
    
84. SHAN W, Liu X, Wang Q
    Teaching NeuroImages: (18)F-FDG-PET/SPM analysis in 3 different stages from a patient with LGI-1 autoimmune encephalitis.
    Neurology. 2019;93:e1917-e1918.
    PubMed    
    
    
    
85. GRAFF-RADFORD J, Gunter JL, Jones DT, Przybelski SA, et al
    Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.
    Neurology. 2019 Nov 12. pii: WNL.0000000000008616.
    PubMed     Abstract available
    
    
    
86. SUNDERMANN EE, Maki P, Biegon A, Lipton RB, et al
    Sex-specific norms for verbal memory tests may improve diagnostic accuracy of amnestic MCI.
    Neurology. 2019;93:e1881-e1889.
    PubMed     Abstract available
    
    
    October 2019
87. ALTOMARE D, de Wilde A, Ossenkoppele R, Pelkmans W, et al
    Applying the ATN scheme in a memory clinic population: The ABIDE project.
    Neurology. 2019;93:e1635-e1646.
    PubMed     Abstract available
    
    
    
88. SCHINDLER SE, Bollinger JG, Ovod V, Mawuenyega KG, et al
    High-precision plasma beta-amyloid 42/40 predicts current and future brain amyloidosis.
    Neurology. 2019;93:e1647-e1659.
    PubMed     Abstract available
    
    
    
89. VAGAL A, Wintermark M, Nael K, Bivard A, et al
    Automated CT perfusion imaging for acute ischemic stroke: Pearls and pitfalls for real-world use.
    Neurology. 2019 Oct 21. pii: WNL.0000000000008481.
    PubMed     Abstract available
    
    
    September 2019
90. DEBOER SR, Lesche S, Rodriguez FJ, Ostrow LW, et al
    Teaching NeuroImages: Neurolymphomatosis.
    Neurology. 2019;93:e1229-e1230.
    PubMed    
    
    
    August 2019
91. AHLAWAT S, Blakeley JO, Rodriguez FJ, Fayad LM, et al
    Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Neurology. 2019 Aug 8. pii: WNL.0000000000008092.
    PubMed     Abstract available
    
    
    July 2019
92. NEITZEL J, Franzmeier N, Rubinski A, Ewers M, et al
    Left frontal connectivity attenuates the adverse effect of entorhinal tau pathology on memory.
    Neurology. 2019;93:e347-e357.
    PubMed     Abstract available
    
    
    
93. MIELKE MM, Syrjanen JA, Blennow K, Zetterberg H, et al
    Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures.
    Neurology. 2019;93:e252-e260.
    PubMed     Abstract available
    
    
    
94. INSEL PS, Weiner M, Mackin RS, Mormino E, et al
    Determining clinically meaningful decline in preclinical Alzheimer disease.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007831.
    PubMed     Abstract available
    
    
    
95. BISCHOF GN, Jacobs HIL
    Subthreshold amyloid and its biological and clinical meaning: Long way ahead.
    Neurology. 2019;93:72-79.
    PubMed     Abstract available
    
    
    June 2019
96. SHIRVAN J, Clement N, Ye R, Katz S, et al
    Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.
    Neurology. 2019 Jun 26. pii: WNL.0000000000007855.
    PubMed     Abstract available
    
    
    May 2019
97. LOWE VJ, Bruinsma TJ, Wiste HJ, Min HK, et al
    Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults.
    Neurology. 2019 May 30. pii: WNL.0000000000007728.
    PubMed     Abstract available
    
    
    
98. UNTERRAINER M, Ruf V, Ilhan H, Vettermann F, et al
    Teaching NeuroImages: Advanced imaging of neurosarcoidosis with (68)Ga-DOTATATE PET/CT.
    Neurology. 2019;92:e2512-e2513.
    PubMed    
    
    
    
99. VERMUNT L, van Paasen AJL, Teunissen CE, Scheltens P, et al
    Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal.
    Neurology. 2019 May 8. pii: WNL.0000000000007609.
    PubMed     Abstract available
    
    
    
100. NA S, Lee ES, Kim YD
     Teaching NeuroImages: Pterygoid myositis mimicking giant cell arteritis.
     Neurology. 2019;92:e2297.
     PubMed    
     
     
     
101. TIAN H, Parsons MW, Levi CR, Lin L, et al
     Influence of occlusion site and baseline ischemic core on outcome in ischemic stroke patients.
     Neurology. 2019 May 1. pii: WNL.0000000000007553.
     PubMed     Abstract available
     
     
     
102. MUIR KW, Yan B
     Perfusion imaging INSPIREs precision medicine in stroke.
     Neurology. 2019 May 1. pii: WNL.0000000000007554.
     PubMed    
     
     
     April 2019
103. FEDERAU C, Wintermark M, Christensen S, Mlynash M, et al
     Collateral blood flow measurement with intravoxel incoherent motion perfusion imaging in hyperacute brain stroke.
     Neurology. 2019 Apr 24. pii: WNL.0000000000007538.
     PubMed     Abstract available
     
     
     
104. MCKINLEY R, Marshall R
     Advanced MRI in acute stroke: Is the whole penumbra salvageable?
     Neurology. 2019 Apr 24. pii: WNL.0000000000007535.
     PubMed    
     
     
     
105. MARIE S, Comtat C, Caille F, Becquemont L, et al
     (11)C-glyburide PET imaging unveils the negligible brain penetration of glyburide in humans.
     Neurology. 2019;92:813-814.
     PubMed    
     
     
     
106. ERICKSON CM, Schultz SA, Oh JM, Darst BF, et al
     KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD.
     Neurology. 2019;92:e1878-e1889.
     PubMed     Abstract available
     
     
     
107. KANG SW, Jeon S, Yoo HS, Chung SJ, et al
     Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.
     Neurology. 2019 Apr 3. pii: WNL.0000000000007373.
     PubMed     Abstract available
     
     
     March 2019
108. ALBRECHT DS, Mainero C, Ichijo E, Ward N, et al
     Imaging of neuroinflammation in migraine with aura: A [(11)C]PBR28 PET/MRI study.
     Neurology. 2019 Mar 27. pii: WNL.0000000000007371.
     PubMed     Abstract available
     
     
     
109. PLANCHE V, Vergnet S, Auzou N, Bonnet M, et al
     Acute toxic limbic encephalopathy following glyphosate intoxication.
     Neurology. 2019;92:534-536.
     PubMed    
     
     
     
110. HAIGHT T, Mendiola C, Solnes L, Cohen M, et al
     Cortical and bithalamic hypometabolism by FDG-PET/CT in a patient with sporadic fatal insomnia.
     Neurology. 2019 Mar 6. pii: WNL.0000000000007240.
     PubMed    
     
     
     February 2019
111. FEMMINELLA GD, Dani M, Wood M, Fan Z, et al
     Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume.
     Neurology. 2019 Feb 22. pii: WNL.0000000000007133.
     PubMed     Abstract available
     
     
     
112. OH J, Ontaneda D, Azevedo C, Klawiter EC, et al
     Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.
     Neurology. 2019 Feb 20. pii: WNL.0000000000007099.
     PubMed     Abstract available
     
     
     
113. SUBRAMANIAM T, Jain A, Hall LT, Cole AJ, et al
     Lateralized periodic discharges frequency correlates with glucose metabolism.
     Neurology. 2019;92:e670-e674.
     PubMed     Abstract available
     
     
     January 2019
114. PARDINI M, Huey ED, Spina S, Kreisl WC, et al
     FDG-PET patterns associated with underlying pathology in corticobasal syndrome.
     Neurology. 2019 Jan 30. pii: WNL.0000000000007038.
     PubMed     Abstract available
     
     
     
115. TSAI HH, Pasi M, Tsai LK, Chen YF, et al
     Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study.
     Neurology. 2019 Jan 23. pii: WNL.0000000000006953.
     PubMed     Abstract available
     
     
     
116. DAY GS, Gordon BA, Perrin RJ, Ances BM, et al
     Author response: In vivo [(18)F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.
     Neurology. 2019;92:150.
     PubMed    
     
     
     
117. YUAN J, Hu W
     Reader response: In vivo [(18)F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.
     Neurology. 2019;92:149.
     PubMed    
     
     
     
118. SIEGLER JE 3RD, Galetta S
     Editors' note: In vivo [(18)F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.
     Neurology. 2019;92:149.
     PubMed    
     
     
     
119. RHEIMS S, Alvarez BM, Alexandre V, Curot J, et al
     Hypoxemia following generalized convulsive seizures: Risk factors and effect of oxygen therapy.
     Neurology. 2019;92:e183-e193.
     PubMed     Abstract available
     
     
     
120. GRAFF-RADFORD J, Botha H, Rabinstein AA, Gunter JL, et al
     Cerebral microbleeds: Prevalence and relationship to amyloid burden.
     Neurology. 2019;92:e253-e262.
     PubMed     Abstract available
     
     
     
121. SCHOBERL F, Irving S, Pradhan C, Bardins S, et al
     Prolonged allocentric navigation deficits indicate hippocampal damage in TGA.
     Neurology. 2019;92:e234-e243.
     PubMed     Abstract available
     
     
     
122. WHITWELL JL, Martin PR, Duffy JR, Clark HM, et al
     The influence of beta-amyloid on [(18)F]AV-1451 in semantic variant of primary progressive aphasia.
     Neurology. 2019 Jan 11. pii: WNL.0000000000006913.
     PubMed     Abstract available
     
     
     
123. OSSENKOPPELE R, Smith R, Ohlsson T, Strandberg O, et al
     Associations between tau, Abeta, and cortical thickness with cognition in Alzheimer disease.
     Neurology. 2019 Jan 9. pii: WNL.0000000000006875.
     PubMed     Abstract available
     
     
     
124. DUEZ L, Tankisi H, Hansen PO, Sidenius P, et al
     Electromagnetic source imaging in presurgical workup of patients with epilepsy: A prospective study.
     Neurology. 2019 Jan 4. pii: WNL.0000000000006877.
     PubMed     Abstract available
     
     
     December 2018
125. SHINOTOH H, Shimada H, Kokubo Y, Tagai K, et al
     Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula.
     Neurology. 2018 Dec 7. pii: WNL.0000000000006736.
     PubMed     Abstract available
     
     
     November 2018
126. MAHLER C, Unterrainer M, Muth C, Egensperger R, et al
     Imaging microglial activation in tacrolimus-associated CNS vasculitis with translocator protein PET.
     Neurology. 2018;91:936-937.
     PubMed    
     
     
     September 2018
127. HAMMOUD DA, Sinharay S, Steinbach S, Wakim PG, et al
     Global and regional brain hypometabolism on FDG-PET in treated HIV-infected individuals.
     Neurology. 2018 Sep 26. pii: WNL.0000000000006398.
     PubMed     Abstract available
     
     
     
128. BAHEERATHAN A, McNamara C, Kalam S, Rane N, et al
     The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab.
     Neurology. 2018;91:572-573.
     PubMed    
     
     
     
129. CHARIDIMOU A, Giese AK, Pasi M, van Veluw SJ, et al
     Journal Club: Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.
     Neurology. 2018;91:574-577.
     PubMed    
     
     
     August 2018
130. CRISWELL SR, Warden MN, Searles Nielsen S, Perlmutter JS, et al
     Selective D2 receptor PET in manganese-exposed workers.
     Neurology. 2018 Aug 10. pii: WNL.0000000000006163.
     PubMed     Abstract available
     
     
     
131. PAGANO G, De Micco R, Yousaf T, Wilson H, et al
     REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
     Neurology. 2018 Aug 8. pii: WNL.0000000000006134.
     PubMed     Abstract available
     
     
     
132. ASCHENBRENNER AJ, Gordon BA, Benzinger TLS, Morris JC, et al
     Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease.
     Neurology. 2018 Aug 1. pii: WNL.0000000000006075.
     PubMed     Abstract available
     
     
     July 2018
133. MARANGI A, Tagliapietra M, Vicenzi V, Pasquin I, et al
     Teaching NeuroImages: Brain MRI and DaT-SPECT imaging in adult GM1 gangliosidosis.
     Neurology. 2018;91:e187-e188.
     PubMed    
     
     
     May 2018
134. BOOT E, Butcher NJ, Udow S, Marras C, et al
     Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.
     Neurology. 2018 May 11. pii: WNL.0000000000005660.
     PubMed     Abstract available
     
     
     April 2018
135. PASSAMONTI L, Rodriguez PV, Hong YT, Allinson KSJ, et al
     [(11)C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy.
     Neurology. 2018 Apr 27. pii: WNL.0000000000005610.
     PubMed     Abstract available
     
     
     
136. BERTI V, Walters M, Sterling J, Quinn CG, et al
     Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.
     Neurology. 2018 Apr 13. pii: WNL.0000000000005527.
     PubMed     Abstract available
     
     
     
137. PAGANO G, Polychronis S, Wilson H, Giordano B, et al
     Diabetes mellitus and Parkinson disease.
     Neurology. 2018 Apr 6. pii: WNL.0000000000005475.
     PubMed     Abstract available
     
     
     March 2018
138. HUANG YS, Hsiao IT, Liu FY, Hwang FM, et al
     Neurocognition, sleep, and PET findings in type 2 vs type 1 narcolepsy.
     Neurology. 2018 Mar 30. pii: WNL.0000000000005346.
     PubMed     Abstract available
     
     
     
139. HUGHES TM, Wagenknecht LE, Craft S, Mintz A, et al
     Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study.
     Neurology. 2018 Mar 16. pii: WNL.0000000000005259.
     PubMed     Abstract available
     
     
     February 2018
140. PILOTTO A, Premi E, Paola Caminiti S, Presotto L, et al
     Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
     Neurology. 2018 Feb 16. pii: WNL.0000000000005161.
     PubMed     Abstract available
     
     
     
141. JONES DT, Knopman DS, Graff-Radford J, Syrjanen JA, et al
     In vivo (18)F-AV-1451 tau-PET signal in MAPT mutation carriers varies by expected tau isoforms.
     Neurology. 2018 Feb 9. pii: WNL.0000000000005117.
     PubMed     Abstract available
     
     
     
142. DAY GS, Gordon BA, Perrin RJ, Cairns NJ, et al
     In vivo [(18)F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.
     Neurology. 2018 Feb 7. pii: WNL.0000000000005064.
     PubMed     Abstract available
     
     
     
143. BOTHA H, Mantyh WG, Graff-Radford J, Machulda MM, et al
     Tau-negative amnestic dementia masquerading as Alzheimer disease dementia.
     Neurology. 2018 Feb 7. pii: WNL.0000000000005124.
     PubMed     Abstract available
     
     
     January 2018
144. OTTO M
     Tau CSF proteins for diagnosis but tau PET imaging for AD diagnosis and staging.
     Neurology. 2018 Jan 10. pii: WNL.0000000000004902.
     PubMed    
     
     
     
145. MATTSSON N, Smith R, Strandberg O, Palmqvist S, et al
     Comparing (18)F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.
     Neurology. 2018 Jan 10. pii: WNL.0000000000004887.
     PubMed     Abstract available
     
     
     
146. FUJIMAKI M, Saiki S, Li Y, Kaga N, et al
     Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
     Neurology. 2018 Jan 3. pii: WNL.0000000000004888.
     PubMed     Abstract available
     
     
     December 2017
147. LA JOIE R, Bejanin A, Fagan AM, Ayakta N, et al
     Associations between [(18)F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample.
     Neurology. 2017 Dec 27. pii: WNL.0000000000004860.
     PubMed     Abstract available
     
     
     
148. GONNEAUD J, Arenaza-Urquijo EM, Mezenge F, Landeau B, et al
     Increased florbetapir binding in the temporal neocortex from age 20 to 60 years.
     Neurology. 2017;89:2438-2446.
     PubMed     Abstract available
     
     
     November 2017
149. GROTHE MJ, Barthel H, Sepulcre J, Dyrba M, et al
     In vivo staging of regional amyloid deposition.
     Neurology. 2017;89:2031-2038.
     PubMed     Abstract available
     
     
     
150. VOGEL JW, Varga Dolezalova M, La Joie R, Marks SM, et al
     Subjective cognitive decline and beta-amyloid burden predict cognitive change in healthy elderly.
     Neurology. 2017;89:2002-2009.
     PubMed     Abstract available
     
     
     October 2017
151. LANDIN-ROMERO R, Kumfor F
     Letter re: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
     Neurology. 2017;89:1931.
     PubMed    
     
     
     
152. CHETELAT G, Murray ME
     Amyloid PET scan: Staging beyond reading?
     Neurology. 2017 Oct 18. pii: 10.1212/WNL.0000000000004678.
     PubMed    
     
     
     
153. MOLLENHAUER B, Caspell-Garcia CJ, Coffey CS, Taylor P, et al
     Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.
     Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004609.
     PubMed     Abstract available
     
     
     
154. ROBERTS RO, Knopman DS, Syrjanen JA, Aakre JA, et al
     Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.
     Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004652.
     PubMed     Abstract available
     
     
     September 2017
155. CHO H, Baek MS, Choi JY, Lee SH, et al
     18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome.
     Neurology. 2017;89:1170-1178.
     PubMed     Abstract available
     
     
     
156. LIM YY, Mormino EC
     APOE genotype and early beta-amyloid accumulation in older adults without dementia.
     Neurology. 2017;89:1028-1034.
     PubMed     Abstract available
     
     
     August 2017
157. CHARIDIMOU A, Farid K, Baron JC
     Amyloid-PET in sporadic cerebral amyloid angiopathy: A diagnostic accuracy meta-analysis.
     Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004539.
     PubMed     Abstract available
     
     
     
158. RAPOSO N, Sonnen JA
     Amyloid-PET in cerebral amyloid angiopathy: Detecting vascular amyloid deposits, not just blood.
     Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004548.
     PubMed    
     
     
     
159. MOSCONI L, Berti V, Quinn C, McHugh P, et al
     Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.
     Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004425.
     PubMed     Abstract available
     
     
     
160. NEDELSKA Z, Przybelski SA, Lesnick TG, Schwarz CG, et al
     1H-MRS metabolites and rate of beta-amyloid accumulation on serial PET in clinically normal adults.
     Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004421.
     PubMed     Abstract available
     
     
     
161. SMITH R, Scholl M, Widner H, van Westen D, et al
     In vivo retention of 18F-AV-1451 in corticobasal syndrome.
     Neurology. 2017;89:845-853.
     PubMed     Abstract available
     
     
     July 2017
162. RAPOSO N, Planton M, Peran P, Payoux P, et al
     Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.
     Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004228.
     PubMed     Abstract available
     
     
     
163. NICCOLINI F, Wilson H, Pagano G, Coello C, et al
     Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
     Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004201.
     PubMed     Abstract available
     
     
     
164. SIERRA M, Martinez-Rodriguez I, Sanchez-Juan P, Gonzalez-Aramburu I, et al
     Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
     Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004185.
     PubMed     Abstract available
     
     
     June 2017
165. BUCKLEY RF, Schultz AP, Hedden T, Papp KV, et al
     Functional network integrity presages cognitive decline in preclinical Alzheimer disease.
     Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004059.
     PubMed     Abstract available
     
     
     May 2017
166. CARRERA E, Wintermark M
     Imaging-based selection of patients for acute stroke treatment: Is it ready for prime time?
     Neurology. 2017 May 17. pii: 10.1212/WNL.0000000000004051.
     PubMed    
     
     
     
167. HOSSACK M, McClean J
     Pure sensory ganglionopathy as the first sign of relapse in non-Hodgkin lymphoma.
     Neurology. 2017;88:1976-1977.
     PubMed    
     
     
     
168. VANNINI P, Hanseeuw B, Munro CE, Amariglio RE, et al
     Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden.
     Neurology. 2017;88:1759-1767.
     PubMed     Abstract available
     
     
     April 2017
169. LI Y, Kang W, Yang Q, Zhang L, et al
     Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases.
     Neurology. 2017;88:1493-1500.
     PubMed     Abstract available
     
     
     
170. NG KP, Pascoal TA, Mathotaarachchi S, Chung CO, et al
     Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
     Neurology. 2017 Apr 12. pii: 10.1212/WNL.0000000000003916.
     PubMed     Abstract available
     
     
     March 2017
171. DASILVA AF, Nascimento TD, Jassar H, Heffernan J, et al
     Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.
     Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003861.
     PubMed     Abstract available
     
     
     
172. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
     Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
     Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
     PubMed     Abstract available
     
     
     
173. PAPP KV, Rentz DM, Mormino EC, Schultz AP, et al
     Cued memory decline in biomarker-defined preclinical Alzheimer disease.
     Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003812.
     PubMed     Abstract available
     
     
     February 2017
174. FRANZMEIER N, Duering M, Weiner M, Dichgans M, et al
     Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.
     Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003711.
     PubMed     Abstract available
     
     
     
175. KREISL WC, Lawrence R, Page E, Teich AF, et al
     11C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer disease.
     Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003693.
     PubMed    
     
     
     
176. GROTHE MJ, Villeneuve S, Dyrba M, Bartres-Faz D, et al
     Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.
     Neurology. 2017;88:569-576.
     PubMed     Abstract available
     
     
     January 2017
177. THOMAS AJ, Attems J, Colloby SJ, O'Brien JT, et al
     Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.
     Neurology. 2017;88:276-283.
     PubMed     Abstract available
     
     
     November 2016
178. SETHI M, Kowalczyk MA, Dalic LJ, Archer JS, et al
     Abnormal neurovascular coupling during status epilepticus migrainosus in Sturge-Weber syndrome.
     Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003492.
     PubMed    
     
     
     
179. PAGANO G, Molloy S, Bain PG, Rabiner EA, et al
     Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
     Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003396.
     PubMed     Abstract available
     
     
     October 2016
180. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
     Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
     Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
     PubMed     Abstract available
     
     
     September 2016
181. MATTSSON N, Zetterberg H, Janelidze S, Insel PS, et al
     Plasma tau in Alzheimer disease.
     Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003246.
     PubMed     Abstract available
     
     
     
182. VAUGHAN DN, Rayner G, Tailby C, Jackson GD, et al
     MRI-negative temporal lobe epilepsy: A network disorder of neocortical connectivity.
     Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003289.
     PubMed     Abstract available
     
     
     August 2016
183. BURNHAM SC, Rowe CC, Baker D, Bush AI, et al
     Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up.
     Neurology. 2016 Aug 17. pii: 10.1212/WNL.0000000000003094.
     PubMed     Abstract available
     
     
     July 2016
184. KNOPMAN DS, Jack CR Jr, Wiste HJ, Weigand SD, et al
     Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.
     Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000002979.
     PubMed     Abstract available
     
     
     
185. MORMINO EC, Sperling RA, Holmes AJ, Buckner RL, et al
     Polygenic risk of Alzheimer disease is associated with early- and late-life processes.
     Neurology. 2016 Jul 6. pii: 10.1212/WNL.0000000000002922.
     PubMed     Abstract available
     
     
     May 2016
186. VASSILAKI M, Aakre JA, Mielke MM, Geda YE, et al
     Multimorbidity and neuroimaging biomarkers among cognitively normal persons.
     Neurology. 2016;86:2077-84.
     PubMed     Abstract available
     
     
     
187. VOEVODSKAYA O, Sundgren PC, Strandberg O, Zetterberg H, et al
     Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
     Neurology. 2016;86:1754-61.
     PubMed     Abstract available
     
     
     April 2016
188. INSEL PS, Mattsson N, Mackin RS, Scholl M, et al
     Accelerating rates of cognitive decline and imaging markers associated with beta-amyloid pathology.
     Neurology. 2016 Apr 15. pii: 10.1212/WNL.0000000000002683.
     PubMed     Abstract available
     
     
     March 2016
189. LIM YY, Laws SM, Villemagne VL, Pietrzak RH, et al
     Abeta-related memory decline in APOE epsilon4 noncarriers: Implications for Alzheimer disease.
     Neurology. 2016 Mar 30. pii: 10.1212/WNL.0000000000002604.
     PubMed     Abstract available
     
     
     
190. LANDAU SM, Horng A, Fero A, Jagust WJ, et al
     Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
     Neurology. 2016 Mar 11. pii: 10.1212/WNL.0000000000002576.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: